Clinical Trial Update: Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

View source ↗

Summary

Clinical trial update exploring mesothelin and osteopontin as diagnostic markers for malignant mesothelioma and atypical mesothelial hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Mesothelial Hyperplasia
• Malignant Mesothelioma

Snippet

Sponsor: University Hospital, Caen | Conditions: Malignant Mesothelioma, Metastatic Cancer | Status: UNKNOWN